rp-3500

Small moleculeexperimental

Chemistry & pharmacology

Loading structure…

SMILES

C[C@@H]1COCCN1c1cc([C@]2(O)C[C@H]3CC[C@@H](C2)O3)c2cnn(-c3cc[nH]n3)c2n1
Mol. weight
410.48 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07156227Phase 1Dec 26, 2025National Cancer Institute (NCI), University of Pittsburgh
NCT05566574Phase 1/Phase 2 (Phase 2)Sep 30, 2022Memorial Sloan-Kettering Cancer Center, Repare Therapeutics
NCT05405309Phase 1/Phase 2 (Phase 2)Sep 23, 2022Repare Therapeutics, University of Utah
NCT04972110Phase 1/Phase 2 (Phase 2)Jul 21, 2021Repare Therapeutics
NCT04497116Phase 1/Phase 2 (Phase 2)Jul 22, 2020Repare Therapeutics, University of Texas at Houston
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Repare TherapeuticsFor profit4212020
Memorial Sloan-Kettering Cancer CenterAcademic/Hospital1112022
National Cancer Institute (NCI)Government1112025
University of PittsburghAcademic/Hospital1012025
University of Texas at HoustonAcademic/Hospital1012020
University of UtahAcademic/Hospital1112022
6 organizations
Page 1 / 1